Amanote Research
Register
Sign In
Cationic Amphiphilic Drugs Boost the Lysosomal Escape of Small Nucleic Acid Therapeutics in a Nanocarrier-Dependent Manner
doi 10.1021/acsnano.0c00666.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Natural and Artificial Small RNAs: A Promising Avenue of Nucleic Acid Therapeutics for Cancer
Cancer Biology and Medicine
Cancer Research
Oncology
Nucleic Acid–Based Therapeutics for Parkinson’s Disease
Neurotherapeutics
Neurology
Pharmacology
RALA-mediated Delivery of FKBPL Nucleic Acid Therapeutics
Nanomedicine
Development
Materials Science
Nanoscience
Medicine
Bioengineering
Nanotechnology
Biomedical Engineering
A Novel Biomarker for Cellular Toxicity and Phospholipid Accumulation by Cationic Amphiphilic Drugs
CHROMATOGRAPHY
Acid-Degradable Cationic Dextran Particles for the Delivery of siRNA Therapeutics
Bioconjugate Chemistry
Organic Chemistry
Biotechnology
Pharmacology
Pharmaceutical Science
Bioengineering
Biomedical Engineering
Advancements in Nucleic Acid Based Therapeutics Against Respiratory Viral Infections
Journal of Clinical Medicine
Selective Tissue Targeting of Synthetic Nucleic Acid Drugs
Journal of Clinical Investigation
Medicine
Amphiphilic Small Molecule Assemblies to Enhance the Solubility and Stability of Hydrophobic Drugs
The Nucleic Acid Database: A Resource for Nucleic Acid Science
Acta Crystallographica Section D Biological Crystallography